Citius Oncology, Inc.
CTOR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851484
No open-market purchases or sales by Citius Oncology, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.20M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Citius Oncology, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 7 | 11 | +4 |
| Shares | 41.2K | 200.9K | +159.6K (+387.1%) |
| Value | $57.0K | $230.2K | +$173.2K (+303.7%) |
New holders (5)
Institutions that held Citius Oncology, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 68,543 | $78.0K | 0.00% |
| Citadel Advisors LLC | 22,699 | $26.1K | 0.00% |
| XTX Topco Ltd | 21,095 | $24.3K | 0.00% |
| Geode Capital Management, LLC | 12,651 | $14.5K | 0.00% |
| Renaissance Technologies LLC | 11,196 | $12.9K | 0.00% |
Sold out (1)
Institutions that held Citius Oncology, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Virtu Financial LLC | 10,291 | $14.0K |